1. Martin Tj, Sim NK. Regulatory pathways reveal new approaches to the development of anabolic drugs for osteoporosis. Osteoporosis Int. 2008; 19: 1139-45. [
DOI:10.1007/s00198-008-0575-5] [
PMID]
2. Refsum H, Veland PM. Homocysteine and cardio vascular dis. Annu Rev med. 1998; 49: 31-62. [
DOI:10.1146/annurev.med.49.1.31] [
PMID]
3. Clarke R, Smith AD. Folate, Vit-B12, and serum total homocysteine levels in confirmed alzheimer disease. Arch Neurol.1998; 11: 1449-55. [
DOI:10.1001/archneur.55.11.1449] [
PMID]
4. Lubec B, Fang-kircher S. Evidence for MC kusick's hypothesis of deficient collagen cross-linking in patients with Homocystinuria. Biochim Biophys Acta. 1996; 1315: 159-62. [
DOI:10.1016/0925-4439(95)00119-0]
5. Saito M, Fuji K, Degree of mineralization-related collagen cross linking in the femoral neck cancellous bone in cases of hip fracture and controls. Calcifi Tissue Int. 2006; 79: 160-8. [
DOI:10.1007/s00223-006-0035-1] [
PMID]
6. Krumdieck CL, prince CW. Mechanisms of homocysteine toxicity on connective tissue implications for morbidity of aging. J Nutr. 2000; 130: 3655-83. [
DOI:10.1093/jn/130.2.365S] [
PMID]
7. Mclean RR, Jacques PF. Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med. 2004; 350: 2042-9. [
DOI:10.1056/NEJMoa032739] [
PMID]
8. LeBoff MS, Narweker R, Lacroix A, et al. Homocysteine levels and risk of hip fracture in postmenopausal women. J Clin Endocrinol Metab. 2009; 94: 1207-13. [
DOI:10.1210/jc.2008-1777] [
PMID] [
PMCID]
9. Mudd SH, Skouby F. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet. 1985; 37: 1-31.
10. Golbahar J, Hamidi A, Aminzadeh MA. Association of plasma folate, plasma total homocysteine but not methylen tetrahydrofolate reductase C6677 polymorphism with BMD in postmenopausal. Iranian woman: a cross sectional study. Bone. 2004; 35: 760-5. [
DOI:10.1016/j.bone.2004.04.018] [
PMID]
11. Morris MS, Jacques PF. Relation between Hcy and B- vitamins statues indicators and BMD in older Americans. Bone. 2005; 37: 234-42. [
DOI:10.1016/j.bone.2005.04.017] [
PMID]
12. Rassmussen LB, Ovesen L, Bulow I, et al. Folate intake lifestyle factors, and homocysteine concentrations in younger and older woman. Am J clin Nut. 2000; 72: 1156-63. [
DOI:10.1093/ajcn/72.5.1156] [
PMID]
13. Das UN. Folic acid says no to vascular disease. Nutrition. 2003; 19: 686-92. [
DOI:10.1016/S0899-9007(02)01044-4]
14. Stone KL, Baner DC. Low serum vit- B12 levels are associated with increased hip bone loss in older women: a prospective study. J Clin Endocrinol Metab. 2004; 89: 1214-21. [
DOI:10.1210/jc.2003-030074] [
PMID]
15. Dhonukshe-Rutten RA, Lips M. Vit - B12 status is associated with bone mineral content and BMD in frail elderly women but not in men. JNut. 2003; 133: 801-7 [
DOI:10.1093/jn/133.3.801] [
PMID]
16. Tucker KL, Hannan MT. Low plasma Vit- B12 associated with lower BMD: The Framingham osteoporosis study. J Bone Miner Res. 2005; 20: 152-8. [
DOI:10.1359/jbmr.2005.20.1.152]
17. Cagnacci A, Baldassari F. Relation of homocysteine, folate and B12 to BMD of postmenopausal women. Bone. 2003; 33: 956-9. [
DOI:10.1016/j.bone.2003.07.001] [
PMID]
18. Sato Y, Honda Y. Effect of folate and metcobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA. 2005; 293: 1082-8. [
DOI:10.1001/jama.293.9.1082] [
PMID]
19. McLean RR, JacquesPF, Selhub J, et al. Plasma B vitamins, homocysteine, and their relation with bone loss and hip fracture in elderly men and women. J Clin Endocrinol Metab. 2008; 93: 2206-12. [
DOI:10.1210/jc.2007-2710] [
PMID] [
PMCID]
20. Van Meurs JB. Homocysteine levels and the risk of osteoporotic fractures. N Eng J Med. 2004; 35: 2033-41. [
DOI:10.1056/NEJMoa032546] [
PMID]
21. Sato Y, Honda Y. Homocysteine as a predictive factor for hip fracture in stroke patients. Bone. 2005; 36: 721-6. [
DOI:10.1016/j.bone.2005.01.011] [
PMID]
22. Cagnocci A, Bagni B, Relation of folate, vit- B12 and homocystein to vertebral BMD change in postmenopausal women. A five- year longitudinal evaluation. Bone. 2008; 42: 314-20. [
DOI:10.1016/j.bone.2007.10.022] [
PMID]
23. Koh JM, Lee YS. Homocysteine enhances bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation. J Bone Miner Res. 2006; 21: 1003-11. [
DOI:10.1359/jbmr.060406] [
PMID]
24. Khan M, Yamaguchi M. Homocysteine decreases chondrocyte mediated matrix mineralization in differentiating chick limb-bud mesenchymal cells micromass cultures. Bone. 2001; 28: 387-98. [
DOI:10.1016/S8756-3282(01)00409-4]
25. Morris MS, Relation between homocysteine and vit - B12 status indicators and BMD in older Americans. Bone. 2005; 37: 234-42. [
DOI:10.1016/j.bone.2005.04.017] [
PMID]
26. Melton ME, Kochman ML. Reversal of severe osteoporosis with vit - B12 and etidronate therapy in a patient with pernicious Anemia. Metabolism. 1994; 43: 468-9. [
DOI:10.1016/0026-0495(94)90078-7]